Known targets — ChEMBL curated mechanism
PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.61 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.43 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 9/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.42 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.42 |
| ▸ | DPP4 | P27487 | 3/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.39 |
| ▸ | FAP | Q12884 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | ARG1 | P05089 | 1/20 | 0.36 |
| ▸ | ARG2 | P78540 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lysine SCHEMBL587923 | 1.00 | GSR (0.61) | GSRRNPEPGNAI3GNAO1GNAI1 | |
| Lysine SCHEMBL17352177 | 0.98 | GSR (0.59) | GSRRNPEPGNAI3GNAO1GNAI1 | |
| Lysine SCHEMBL17352176 | 0.98 | GSR (0.59) | GSRRNPEPGNAI3GNAO1GNAI1 | |
| SCHEMBL31241164 | 0.98 | GSR (0.59) | GSRRNPEPGNAI3GNAO1GNAI1 | |
| Lysine SCHEMBL25283016 | 0.95 | GSR (0.61) | GSRRNPEPGNAI3GNAO1GNAI1 | |
| Lysine SCHEMBL1281705 | 0.95 | GSR (0.61) | GSRRNPEPGNAI3GNAO1GNAI1 | |
| Lysine SCHEMBL5691753 | 0.95 | GSR (0.61) | GSRRNPEPGNAI3GNAO1GNAI1 | |
| Lysine SCHEMBL3427044 | 0.95 | GSR (0.61) | GSRRNPEPGNAI3GNAO1GNAI1 | |
| Lysine SCHEMBL7197544 | 0.95 | GSR (0.61) | GSRRNPEPGNAI3GNAO1GNAI1 | |
| Lysine SCHEMBL1034337 | 0.95 | GSR (0.61) | GSRRNPEPGNAI3GNAO1GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 147 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4532464-A1 | AGRICULTURALLY USEFUL MINERAL AMINO ACID COMPLEXES | Statera Ag, LLC (US) | 2025-04-09 | — | — | EP | claimed |
| EP-4351609-A1 | ORAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF DISORDERS ASSOCIATED WITH MENOPAUSE | Pizeta Pharma S.P.A. (IT) | 2024-04-17 | — | — | EP | claimed |
| WO-2023230428-A1 | AGRICULTURALLY USEFUL MINERAL AMINO ACID COMPLEXES | STATERA AG, LLC (US) | 2023-11-30 | — | — | WO | claimed |
| WO-2022259195-A1 | ORAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF DISORDERS ASSOCIATED WITH MENOPAUSE. | PIZETA PHARMA S.p.A. (IT) | 2022-12-15 | — | — | WO | claimed |
| CN-111960900-A | Water-soluble fertilizer containing traditional Chinese medicine sweet wormwood herb extract of multi-micro silicon-titanium polyglutamic acid | 河南三泽农业科技有限公司 | 2020-11-20 | — | — | CN | claimed |
| CN-111869791-A | Application of cysteamine magnesium as animal feed additive | 辽宁菲迪饲料科技有限责任公司 | 2020-11-03 | — | — | CN | claimed |
| US-10583168-B1 | Nutritional supplements including cardiovascular support components | 4LIFE PATENTS, LLC (US) | 2020-03-10 | — | — | US | claimed |
| CN-110668873-A | Biological humic acid water-soluble fertilizer | 吴娟 | 2020-01-10 | — | — | CN | claimed |
| US-9849157-B2 | Cardiovascular therapy compositions | 4LIFE PATENTS, LLC (US) | 2017-12-26 | — | — | US | claimed |
| US-9339481-B2 | Phosphate-binding magnesium salts and uses thereof | CYPRESS PHARMACEUTICALS, INC. (US) | 2016-05-17 | — | — | US | claimed |
| US-20150320795-A1 | COMPOSITIONS AND METHODS COMPRISING POLYETHYLENE GLYCOL AND MAGNESIUM FOR TREATMENT OF NEURONAL INJURY | WARSAW ORTHOPEDIC INC. | 2015-11-12 | — | — | US | claimed |
| EP-2931292-A1 | COMPOSITIONS AND METHODS COMPRISING POLYETHYLENE GLYCOL AND MAGNESIUM FOR TREATMENT OF NEURONAL INJURY | Warsaw Orthopedic, Inc. (US) | 2015-10-21 | — | — | EP | claimed |
| WO-2014093918-A1 | COMPOSITIONS AND METHODS COMPRISING POLYETHYLENE GLYCOL AND MAGNESIUM FOR TREATMENT OF NEURONAL INJURY | WARSAW ORTHOPEDIC, INC. (US) | 2014-06-19 | — | — | WO | claimed |
| EP-2416786-A1 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | Cypress Pharmaceutical, Inc. (US) | 2012-02-15 | — | — | EP | claimed |
| US-20110045063-A2 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | CYPRESS PHARMACEUTICAL, INC. (US) | 2011-02-24 | — | — | US | claimed |
| US-7815943-B2 | Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition | 4LIFE RESEARCH, LC (US) | 2010-10-19 | — | — | US | claimed |
| WO-2010117370-A1 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | CYPRESS PHARMACEUTICALS, INC. (US) | 2010-10-14 | — | — | WO | claimed |
| US-20090269399-A1 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | CYPRESS PHARMACEUTICAL, INC. (US) | 2009-10-29 | — | — | US | claimed |
| US-20070243232-A1 | Method to treat and prevent asthma attacks using throat lozenges and orally-retained liquids containing magnesium | EBY III GEORGE A | 2007-10-18 | — | — | US | claimed |
| US-12564644-B2 | Cyclodextrin complexes of specialized proresolving mediators | THETIS PHARMACEUTICALS LLC (US) | 2026-03-03 | — | — | US | disclosed |
| US-20250288630-A1 | HERBAL FORMULATIONS OF CARNIVOROUS PLANTS AND METHODS FOR TREATING INFLAMMATION | GOWEY RESEARCH GROUP, PLLC | 2025-09-18 | — | — | US | disclosed |
| EP-4132299-B1 | VITALITY DIETARY SUPPLEMENT | NESTLE SA (CH) | 2025-06-11 | — | — | EP | disclosed |
| US-12318420-B2 | Herbal formulations of carnivorous plants and methods for treating inflammation | GOWEY RESEARCH GROUP, PLLC (US) | 2025-06-03 | — | — | US | disclosed |
| US-20250134137-A1 | MAGNESIUM SUPPLEMENT FOR POULTRY | TIMAB MAGNESIUM (FR) | 2025-05-01 | — | — | US | disclosed |
| EP-4532464-A1 | AGRICULTURALLY USEFUL MINERAL AMINO ACID COMPLEXES | Statera Ag, LLC (US) | 2025-04-09 | — | — | EP | disclosed |
| EP-4486393-A2 | CYCLODEXTRIN COMPLEXES OF SPECIALIZED PRORESOLVING MEDIATORS | Thetis Pharmaceuticals LLC (US) | 2025-01-08 | — | — | EP | disclosed |
| CN-119136842-A | Cyclodextrin complexes that specialize in resolution mediators | 西蒂斯制药有限责任公司 | 2024-12-13 | — | — | CN | disclosed |
| US-20240408229-A1 | CYCLODEXTRIN COMPLEXES OF SPECIALIZED PRORESOLVING MEDIATORS | THETIS PHARMACEUTICALS LLC (US) | 2024-12-12 | — | — | US | disclosed |
| US-20240374538-A1 | COMPOSITIONS COMPRISING NATURAL PRODUCTS FOR IMPROVING CARBOHYDRATE AND LIPID METABOLISM | GROUPE NATURE PHARMA (CA) | 2024-11-14 | — | — | US | disclosed |
| EP-3927350-B1 | MAGNESIUM SUPPLEMENT FOR POULTRY | TIMAB MAGNESIUM (FR) | 2024-05-22 | — | — | EP | disclosed |
| EP-4351609-A1 | ORAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF DISORDERS ASSOCIATED WITH MENOPAUSE | Pizeta Pharma S.P.A. (IT) | 2024-04-17 | — | — | EP | disclosed |
| US-11925688-B2 | Compositions and methods relating to salts of specialized pro-resolving mediators | THETIS PHARMACEUTICALS LLC (US) | 2024-03-12 | — | — | US | disclosed |
| US-20240041968-A1 | FORMULATIONS FOR WEIGHT LOSS AND METHODS OF USE | GOLO, LLC | 2024-02-08 | — | — | US | disclosed |
| US-20240041969-A1 | FORMULATIONS FOR WEIGHT LOSS AND METHODS OF USE | GOLO, LLC | 2024-02-08 | — | — | US | disclosed |
| US-11883456-B2 | Formulations for weight loss and methods of use | GOLO, LLC (US) | 2024-01-30 | — | — | US | disclosed |
| WO-2023230428-A1 | AGRICULTURALLY USEFUL MINERAL AMINO ACID COMPLEXES | STATERA AG, LLC (US) | 2023-11-30 | — | — | WO | disclosed |
| WO-2023168245-A2 | CYCLODEXTRIN COMPLEXES OF SPECIALIZED PRORESOLVING MEDIATORS | THETIS PHARMACEUTICALS LLC (US) | 2023-09-07 | — | — | WO | disclosed |
| US-20230241153-A1 | METHODS AND COMPOSITIONS FOR UPREGULATING RNA INTERFERENCE AND ENHANCING GENE SILENCING | GOWEY RESEARCH GROUP, PLLC | 2023-08-03 | — | — | US | disclosed |
| EP-4189402-A2 | METHOD AND COMPOSITION OF UPREGULATING RNA INTERFERENCE PROCESS | Gowey Research Group PLLC (US) | 2023-06-07 | — | — | EP | disclosed |
| US-20230157344-A1 | VITALITY DIETARY SUPPLEMENT | NESTLE SA (CH) | 2023-05-25 | — | — | US | disclosed |
| CN-115925473-A | Fish protein polypeptide water-soluble fertilizer and preparation method thereof | 仲恺农业工程学院 | 2023-04-07 | — | — | CN | disclosed |
| US-20230054630-A1 | SLEEP DIETARY SUPPLEMENT | NESTLE SA (CH) | 2023-02-23 | — | — | US | disclosed |
| EP-4132299-A1 | VITALITY DIETARY SUPPLEMENT | Société des Produits Nestlé S.A. (CH) | 2023-02-15 | — | — | EP | disclosed |
| WO-2022259195-A1 | ORAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF DISORDERS ASSOCIATED WITH MENOPAUSE. | PIZETA PHARMA S.p.A. (IT) | 2022-12-15 | — | — | WO | disclosed |
| US-20220347252-A1 | FORMULATIONS FOR WEIGHT LOSS AND METHODS OF USE | GOLO, LLC | 2022-11-03 | — | — | US | disclosed |
| US-11458182-B2 | Formulations for weight loss and methods of use | GOLO LLC (US) | 2022-10-04 | — | — | US | disclosed |
| US-11439614-B2 | Fish egg extracts, omega-3 lipid-based compositions and uses thereof | BIOFLASH INC. | 2022-09-13 | — | — | US | disclosed |
| CN-109562186-B | Compositions and methods relating to salts of specialized proresolving mediators | 西蒂斯制药有限责任公司 | 2022-09-13 | — | — | CN | disclosed |
| US-20220174988-A1 | AMINO ACID CHELATES FOR REDUCING OXIDATIVE STRESS | CRAIN SCOTT L (US) | 2022-06-09 | — | — | US | disclosed |
| US-11344505-B1 | Herbal formulations of carnivorous plants and methods for treating inflammation | GOWEY RESEARCH GROUP, PLLC (US) | 2022-05-31 | — | — | US | disclosed |
| US-20220117267-A1 | MAGNESIUM SUPPLEMENT FOR POULTRY | TIMAB MAGNESIUM (FR) | 2022-04-21 | — | — | US | disclosed |
| US-20220031851-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS | THETIS PHARMACEUTICALS LLC (US) | 2022-02-03 | — | — | US | disclosed |
| EP-3927350-A1 | MAGNESIUM SUPPLEMENT FOR POULTRY | Timab Magnesium (FR) | 2021-12-29 | — | — | EP | disclosed |
| US-11191840-B2 | Compositions and methods relating to salts of specialized pro-resolving mediators | THETIS PHARMACEUTICALS LLC (US) | 2021-12-07 | — | — | US | disclosed |
| US-11141448-B2 | Formulations for weight loss and methods of use | GOLO LLC (US) | 2021-10-12 | — | — | US | disclosed |
| US-11135298-B2 | Compositions and methods relating to salts of specialized pro-resolving mediators | THETIS PHARMACEUTICALS LLC (US) | 2021-10-05 | — | — | US | disclosed |
| US-20210145915-A1 | FORMULATIONS FOR WEIGHT LOSS AND METHODS OF USE | GOLO LLC | 2021-05-20 | — | — | US | disclosed |
| US-20210138072-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS | THETIS PHARMACEUTICALS LLC | 2021-05-13 | — | — | US | disclosed |
| EP-3795179-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS OF INFLAMMATION | Thetis Pharmaceuticals LLC (US) | 2021-03-24 | — | — | EP | disclosed |
| US-20210060058-A1 | COMPOSITIONS AND METHODS FOR TREATING HYDROGEN SULFIDE-MEDIATED HYPERDYNAMIC CIRCULATION | UNM RAINFOREST INNOVATIONS | 2021-03-04 | — | — | US | disclosed |
| US-20200384051-A1 | HERBAL FORMULATIONS OF CARNIVOROUS PLANTS AND METHODS FOR TREATING INFLAMMATION | GOWEY RESEARCH GROUP, PLLC | 2020-12-10 | — | — | US | disclosed |
| CN-111960900-A | Water-soluble fertilizer containing traditional Chinese medicine sweet wormwood herb extract of multi-micro silicon-titanium polyglutamic acid | 河南三泽农业科技有限公司 | 2020-11-20 | — | — | CN | disclosed |
| CN-111902394-A | Compositions and methods relating to salts of specific pro-inflammatory resolution mediators | 西蒂斯制药有限责任公司 | 2020-11-06 | — | — | CN | disclosed |
| CN-111869791-A | Application of cysteamine magnesium as animal feed additive | 辽宁菲迪饲料科技有限责任公司 | 2020-11-03 | — | — | CN | disclosed |
| WO-2020219756-A1 | AMINO ACID CHELATES FOR REDUCING OXIDATIVE STRESS | CRAIN, SCOTT, L. (US) | 2020-10-29 | — | — | WO | disclosed |
| EP-3717451-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS | Thetis Pharmaceuticals LLC (US) | 2020-10-07 | — | — | EP | disclosed |
| US-10765718-B2 | Formulations for weight loss and methods of use | GOLO LLC (US) | 2020-09-08 | — | — | US | disclosed |
| US-20200261530-A1 | FORMULATIONS FOR WEIGHT LOSS AND METHODS OF USE | GOLO LLC | 2020-08-20 | — | — | US | disclosed |
| EP-3454907-B1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS OF INFLAMMATION | THETIS PHARMACEUTICALS LLC (US) | 2020-07-22 | — | — | EP | disclosed |
| US-20200179521-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS | THETIS PHARMACEUTICALS LLC (US) | 2020-06-11 | — | — | US | disclosed |
| US-20200170280-A1 | METAL COMPLEX OR METAL CHELATE COMPOSITIONS COMPRISING MINIMAL NANOPARTICLES | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2020-06-04 | — | — | US | disclosed |
| US-10638785-B2 | Liquid dietary supplement formulation compositions | Watermins, LLC (US) | 2020-05-05 | — | — | US | disclosed |
| US-10583168-B1 | Nutritional supplements including cardiovascular support components | 4LIFE PATENTS, LLC (US) | 2020-03-10 | — | — | US | disclosed |
| CN-110668873-A | Biological humic acid water-soluble fertilizer | 吴娟 | 2020-01-10 | — | — | CN | disclosed |
| US-10420843-B2 | Compositions and methods relating to salts of specialized pro-resolving mediators | THETIS PHARMACEUTICALS LLC (US) | 2019-09-24 | — | — | US | disclosed |
| US-20190223487-A1 | LIQUID DIETARY SUPPLEMENT FORMULATION COMPOSITIONS | Watermins, LLC | 2019-07-25 | — | — | US | disclosed |
| EP-3218466-B1 | PROCESS FOR PRODUCING A BREWED BEVERAGE OR FOR ISOMERISING ALPHA ACIDS | IFAST NV (BE) | 2019-04-24 | — | — | EP | disclosed |
| US-10251412-B2 | Liquid dietary supplement formulation compositions | WATERMINS LLC | 2019-04-09 | — | — | US | disclosed |
| EP-3454907-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS OF INFLAMMATION | Thetis Pharmaceuticals LLC (US) | 2019-03-20 | — | — | EP | disclosed |
| US-10150784-B2 | Crystal polymorph of magnesium glycinate dihydrate and process for its preparation | CYPRESS PHARMACEUTICALS, INC. (US) | 2018-12-11 | — | — | US | disclosed |
| US-10130719-B2 | Compositions and methods relating to salts of specialized pro-resolving mediators | THETIS PHARMACEUTICALS LLC (US) | 2018-11-20 | — | — | US | disclosed |
| EP-2791066-B1 | LIQUID DIETARY SUPPLEMENT FORMULATION COMPOSITIONS | WATERMINS LLC (US) | 2018-10-31 | — | — | EP | disclosed |
| EP-3157936-B1 | MINERAL AMINO-ACID COMPLEXES OF ACTIVE AGENTS | THETIS PHARMACEUTICALS LLC (US) | 2018-10-17 | — | — | EP | disclosed |
| WO-2018176150-A1 | FISH EGG EXTRACTS, OMEGA-3 LIPID-BASED COMPOSITIONS AND USES THEREOF | BIOFLASH INC. (CA) | 2018-10-04 | — | — | WO | disclosed |
| US-20180280333-A1 | FISH EGG EXTRACTS, OMEGA-3 LIPID-BASED COMPOSITIONS AND USES THEREOF | BIOFLASH INC. (CA) | 2018-10-04 | — | — | US | disclosed |
| WO-2018144911-A1 | FORMULATIONS FOR WEIGHT LOSS AND METHODS OF USE | GOLO LLC (US) | 2018-08-09 | — | — | WO | disclosed |
| US-20180214502-A1 | FORMULATIONS FOR WEIGHT LOSS AND METHODS OF USE | GOLO LLC | 2018-08-02 | — | — | US | disclosed |
| US-20180200375-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS | THETIS PHARMACEUTICALS LLC (US) | 2018-07-19 | — | — | US | disclosed |
| US-9999626-B2 | Mineral amino-acid complexes of active agents | THETIS PHARMACEUTICALS LLC (US) | 2018-06-19 | — | — | US | disclosed |
| US-20180161365-A1 | Phosphate-Binding Magnesium Salts And Uses Thereof | CURRAX PHARMACEUTICALS LLC | 2018-06-14 | — | — | US | disclosed |
| EP-2931292-B1 | COMPOSITIONS AND METHODS COMPRISING POLYETHYLENE GLYCOL AND MAGNESIUM FOR TREATMENT OF NEURONAL INJURY | WARSAW ORTHOPEDIC INC (US) | 2018-06-13 | — | — | EP | disclosed |
| US-20180110751-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS | THETIS PHARMACEUTICALS LLC | 2018-04-26 | — | — | US | disclosed |
| US-9889157-B2 | Phosphate-binding magnesium salts and uses thereof | CYPRESS PHARMACEUTICALS, INC. (US) | 2018-02-13 | — | — | US | disclosed |
| US-9849157-B2 | Cardiovascular therapy compositions | 4LIFE PATENTS, LLC (US) | 2017-12-26 | — | — | US | disclosed |
| WO-2017210604-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS OF INFLAMMATION | THETIS PHARMACEUTICALS LLC (US) | 2017-12-07 | — | — | WO | disclosed |
| EP-3218466-A1 | PROCESS FOR PRODUCING A BREWED BEVERAGE OR FOR BREWING A BEER | Ifast NV (BE) | 2017-09-20 | — | — | EP | disclosed |
| US-20170202875-A1 | Phosphate-Binding Magnesium Salts And Uses Thereof | WILMINGTON SAVINGS FUND SOCIETY, FSB | 2017-07-20 | — | — | US | disclosed |
| EP-3157936-A1 | MINERAL AMINO-ACID COMPLEXES OF ACTIVE AGENTS | Thetis Pharmaceuticals LLC (US) | 2017-04-26 | — | — | EP | disclosed |
| EP-3157936-A1 | MINERAL AMINO-ACID COMPLEXES OF ACTIVE AGENTS | Thetis Pharmaceuticals LLC (US) | 2017-04-26 | — | — | EP | disclosed |
| US-9610267-B2 | Phosphate-binding magnesium salts and uses thereof | CYPRESS PHARMACEUTICALS, INC. (US) | 2017-04-04 | — | — | US | disclosed |
| US-20160326188-A1 | Crystal Polymorph Of Magnesium Glycinate Dihydrate And Process For Its Preparation | WILMINGTON SAVINGS FUND SOCIETY, FSB | 2016-11-10 | — | — | US | disclosed |
| US-20160256420-A1 | Phosphate-Binding Magnesium Salts And Uses Thereof | WILMINGTON SAVINGS FUND SOCIETY, FSB | 2016-09-08 | — | — | US | disclosed |
| US-9394318-B2 | Crystal polymorph of magnesium glycinate dihydrate and process for its preparation | CYPRESS PHARMACEUTICALS, INC. (US) | 2016-07-19 | — | — | US | disclosed |
| US-20160199385-A1 | Mineral Amino-Acid Complexes of Active Agents | CONNECTICUT INNOVATIONS, INC., AS COLLATERAL AGENT | 2016-07-14 | — | — | US | disclosed |
| US-20160192689-A1 | ENCAPSULATED FUNCTIONAL FOOD COMPOSITIONS | Incredible Foods, Inc. | 2016-07-07 | — | — | US | disclosed |
| EP-3027058-A1 | ENCAPSULATED FUNCTIONAL FOOD COMPOSITIONS | Wikifoods, Inc. (US) | 2016-06-08 | — | — | EP | disclosed |
| WO-2016075308-A1 | PROCESS FOR PRODUCING A BREWED BEVERAGE OR FOR BREWING A BEER | IFAST NV (BE) | 2016-05-19 | — | — | WO | disclosed |
| US-9339481-B2 | Phosphate-binding magnesium salts and uses thereof | CYPRESS PHARMACEUTICALS, INC. (US) | 2016-05-17 | — | — | US | disclosed |
| US-9242008-B2 | Mineral amino-acid complexes of fatty acids | THETIS PHARMACEUTICALS LLC (US) | 2016-01-26 | — | — | US | disclosed |
| US-20150366980-A1 | Mineral Amino-Acid Complexes of Fatty Acids | CONNECTICUT INNOVATIONS, INC., AS COLLATERAL AGENT | 2015-12-24 | — | — | US | disclosed |
| WO-2015195491-A1 | MINERAL AMINO-ACID COMPLEXES OF ACTIVE AGENTS | THETIS PHARMACEUTICALS LLC (US) | 2015-12-23 | — | — | WO | disclosed |
| WO-2015195491-A1 | MINERAL AMINO-ACID COMPLEXES OF ACTIVE AGENTS | THETIS PHARMACEUTICALS LLC (US) | 2015-12-23 | — | — | WO | disclosed |
| US-20150320795-A1 | COMPOSITIONS AND METHODS COMPRISING POLYETHYLENE GLYCOL AND MAGNESIUM FOR TREATMENT OF NEURONAL INJURY | WARSAW ORTHOPEDIC INC. | 2015-11-12 | — | — | US | disclosed |
| EP-2931292-A1 | COMPOSITIONS AND METHODS COMPRISING POLYETHYLENE GLYCOL AND MAGNESIUM FOR TREATMENT OF NEURONAL INJURY | Warsaw Orthopedic, Inc. (US) | 2015-10-21 | — | — | EP | disclosed |
| WO-2015017625-A1 | ENCAPSULATED FUNCTIONAL FOOD COMPOSITIONS | WIKIFOODS, INC. (US) | 2015-02-05 | — | — | WO | disclosed |
| EP-2791066-A1 | LIQUID DIETARY SUPPLEMENT FORMULATION COMPOSITIONS | Wadhwa, Manpreet, S. (US) | 2014-10-22 | — | — | EP | disclosed |
| US-20140186408-A1 | CRYSTAL POLYMORPH OF MAGNESIUM GLYCINATE DIHYDRATE AND PROCESS FOR ITS PREPARATION | CYPRESS PHARMACEUTICAL, INC. (US) | 2014-07-03 | — | — | US | disclosed |
| WO-2014093918-A1 | COMPOSITIONS AND METHODS COMPRISING POLYETHYLENE GLYCOL AND MAGNESIUM FOR TREATMENT OF NEURONAL INJURY | WARSAW ORTHOPEDIC, INC. (US) | 2014-06-19 | — | — | WO | disclosed |
| US-20140161955-A1 | Liquid Dietary Supplement Formulation Compositions | WATERMINS LLC | 2014-06-12 | — | — | US | disclosed |
| WO-2013090402-A1 | LIQUID DIETARY SUPPLEMENT FORMULATION COMPOSITIONS | WADHWA MANPREET S (US) | 2013-06-20 | — | — | WO | disclosed |
| US-20120282352-A1 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | CYPRESS PHARMACEUTICAL, INC. (US) | 2012-11-08 | — | — | US | disclosed |
| US-8247000-B2 | Phosphate-binding magnesium salts and uses thereof | CYPRESS PHARMACEUTICAL, INC. (US) | 2012-08-21 | — | — | US | disclosed |
| US-8236358-B1 | Phosphate-binding magnesium salts and uses thereof | CYPRESS PHARMACEUTICAL, INC. (US) | 2012-08-07 | — | — | US | disclosed |
| US-20120195964-A1 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | CYPRESS PHARMACEUTICAL, INC. (US) | 2012-08-02 | — | — | US | disclosed |
| EP-2416786-A1 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | Cypress Pharmaceutical, Inc. (US) | 2012-02-15 | — | — | EP | disclosed |
| US-20110045063-A2 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | CYPRESS PHARMACEUTICAL, INC. (US) | 2011-02-24 | — | — | US | disclosed |
| US-20110033414-A1 | CARDIOVASCULAR THERAPY COMPOSITION INCLUDING TRANSFER FACTOR AND THERAPEUTIC METHODS INCLUDING USE OF THE COMPOSITION | 4LIFE RESEARCH, LC (US) | 2011-02-10 | — | — | US | disclosed |
| US-7815943-B2 | Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition | 4LIFE RESEARCH, LC (US) | 2010-10-19 | — | — | US | disclosed |
| WO-2010117370-A1 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | CYPRESS PHARMACEUTICALS, INC. (US) | 2010-10-14 | — | — | WO | disclosed |
| US-7811352-B2 | Fertilizer compositions and methods of using | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2010-10-12 | — | — | US | disclosed |
| US-7776124-B2 | Fertilizer compositions and methods of using | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2010-08-17 | — | — | US | disclosed |
| US-20090269399-A1 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | CYPRESS PHARMACEUTICAL, INC. (US) | 2009-10-29 | — | — | US | disclosed |
| EP-1937610-A2 | FERTILIZER COMPOSITIONS AND METHODS OF USING | Archer-Daniels-Midland Company (US) | 2008-07-02 | — | — | EP | disclosed |
| US-20080134737-A1 | FERTILIZER COMPOSITIONS AND METHODS OF USING | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2008-06-12 | — | — | US | disclosed |
| US-20070292493-A1 | Pharmaceutical composition and method for the transdermal delivery of calcium | BRIERRE BARBARA T | 2007-12-20 | — | — | US | disclosed |
| US-20070243232-A1 | Method to treat and prevent asthma attacks using throat lozenges and orally-retained liquids containing magnesium | EBY III GEORGE A | 2007-10-18 | — | — | US | disclosed |
| US-20070131010-A1 | FERTILIZER COMPOSITIONS AND METHODS OF USING | ARCHER-DENIELS-MIDLAND COMPANY (US) | 2007-06-14 | — | — | US | disclosed |
| WO-2007047350-A2 | FERTILIZER COMPOSITIONS AND METHODS OF USING | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2007-04-26 | — | — | WO | disclosed |
| WO-2005091872-A2 | PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TRANSDERMAL DELIVERY OF MAGNESIUM | BRIERRE BARBARA T (US) | 2005-10-06 | — | — | WO | disclosed |
| US-20050196434-A1 | Pharmaceutical composition and method for the transdermal delivery of magnesium | BRIERRE BARBARA T (US) | 2005-09-08 | — | — | US | disclosed |
| US-20050196433-A1 | Pharmaceutical composition and method for the transdermal delivery of magnesium | BRIERRE BARBARA T (US) | 2005-09-08 | — | — | US | disclosed |
| US-20040126432-A1 | Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition | 4LIFE PATENTS, LLC | 2004-07-01 | — | — | US | disclosed |
| WO-2004017916-A2 | CARDIOVASCULAR THERAPY COMPOSITION INCLUDING TRANSFER FACTOR AND THERAPEUTIC METHODS INCLUDING USE OF THE COMPOSITION | 4LIFE RESEARCH, LC (US) | 2004-03-04 | — | — | WO | disclosed |
| US-6451341-B1 | ADMINISTERING TO ANIMAL DIETARY SUPPLEMENT COMPRISING BUTYLATED HYDROXYTOLUENE(BHT), BUTYLATED HYDROXYANISOLE(BHA), VITAMIN E, AND B-CAROTENE TO PREVENT SKIN CANCER | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2002-09-17 | — | — | US | disclosed |
| EP-0514451-B1 | DIETARY SUPPLEMENTS COMPRISING VITAMINS AND MINERALS | LIFESCIENCE CORP (US) | 1997-01-15 | — | — | EP | disclosed |
| EP-0514451-A1 | DIETARY SUPPLEMENTS COMPRISING VITAMINS AND MINERALS. | UNIV TEXAS (US) | 1992-11-25 | — | — | EP | disclosed |
| WO-1991011117-A2 | DIETARY SUPPLEMENTS COMPRISING VITAMINS AND MINERALS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-08-08 | — | — | WO | disclosed |
| WO-1991011117-A2 | DIETARY SUPPLEMENTS COMPRISING VITAMINS AND MINERALS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-08-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (17 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10420843-B2 | Compositions and methods relating to salts of specialized pro-resolving mediators | PTGER1, PTGER4, PTGER2 | GSR 1679/4885RNPEP 1435/4885GNAI3 1546/4885 |
| US-20220031851-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS | ALOX15B, LTB4R2, ALOX5 | GSR 705/4885RNPEP 1157/4885GNAI3 663/4885 |
| US-20180200375-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS | ALOX15B, LTB4R2, ALOX5 | GSR 705/4885RNPEP 1157/4885GNAI3 663/4885 |
| US-11191840-B2 | Compositions and methods relating to salts of specialized pro-resolving mediators | ALOX5, ALOX15B, ALOX15 | GSR 802/4885RNPEP 1123/4885GNAI3 746/4885 |
| US-10150784-B2 | Crystal polymorph of magnesium glycinate dihydrate and process for its preparation | G6PC1, MGAM, SLC5A1 | GSR 1733/4885RNPEP 2841/4885GNAI3 283/4885 |
| US-20160326188-A1 | Crystal Polymorph Of Magnesium Glycinate Dihydrate And Process For Its Preparation | G6PC1, MGAM, SLC5A1 | GSR 1733/4885RNPEP 2841/4885GNAI3 283/4885 |
| US-20150366980-A1 | Mineral Amino-Acid Complexes of Fatty Acids | FABP4, FABP3, SLC27A2 | GSR 2273/4885RNPEP 1281/4885GNAI3 2204/4885 |
| US-20140186408-A1 | CRYSTAL POLYMORPH OF MAGNESIUM GLYCINATE DIHYDRATE AND PROCESS FOR ITS PREPARATION | G6PC1, MGAM, SLC5A1 | GSR 1733/4885RNPEP 2841/4885GNAI3 283/4885 |
| US-11925688-B2 | Compositions and methods relating to salts of specialized pro-resolving mediators | ALOX15B, LTB4R2, ALOX5 | GSR 705/4885RNPEP 1157/4885GNAI3 663/4885 |
| US-20200179521-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS | ALOX15B, LTB4R2, ALOX5 | GSR 705/4885RNPEP 1157/4885GNAI3 663/4885 |
| US-11135298-B2 | Compositions and methods relating to salts of specialized pro-resolving mediators | PTGER1, PTGIS, PTGER4 | GSR 2032/4885RNPEP 1288/4885GNAI3 1115/4885 |
| US-20210138072-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS | ALOX5, ALOX15B, ALOX15 | GSR 802/4885RNPEP 1123/4885GNAI3 746/4885 |
| US-20180110751-A1 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS | ALOX15B, LTB4R2, ALOX5 | GSR 705/4885RNPEP 1157/4885GNAI3 663/4885 |
| US-20160199385-A1 | Mineral Amino-Acid Complexes of Active Agents | S100A6, S100A4, SLC7A1 | GSR 4169/4885RNPEP 740/4885GNAI3 1971/4885 |
| US-20240408229-A1 | CYCLODEXTRIN COMPLEXES OF SPECIALIZED PRORESOLVING MEDIATORS | PTGER1, LTB4R2, ALOX5 | GSR 1794/4885RNPEP 2760/4885GNAI3 1591/4885 |
| US-10130719-B2 | Compositions and methods relating to salts of specialized pro-resolving mediators | ALOX5, ALOX15, ALOX12 | GSR 1223/4885RNPEP 976/4885GNAI3 1150/4885 |
| US-12564644-B2 | Cyclodextrin complexes of specialized proresolving mediators | ALOX15, ALOX12, PTGES | GSR 2736/4885RNPEP 3892/4885GNAI3 2830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.